Free for clinicians

Stay on top of the evidence — without the reading pile.

A free research digest tuned to your field of practice. Plain-English summaries, always cited, delivered in the Quicka app and to your inbox.

Get my free digest See the full Quicka platform

No card. No trial countdown. Just the digest.

How it works

Three steps from signup to first issue.

Tell us what you treat, we do the reading, you decide what's worth a deeper look.

Step 1

Pick your profession and interest areas

Tell us your discipline (physiotherapy, osteopathy, exercise physiology, podiatry, dietetics, psychology and more) and the conditions, populations or modalities you actually treat.

Step 2

We find recent, relevant studies and summarise them

Each digest is grounded in real, indexed literature — never invented. Summaries stick to what the paper actually says, with limitations called out where they matter.

Step 3

Read in-app and inbox, save a reading list

New issues arrive in the Quicka app and in your email. Star the ones worth a deeper read, archive the rest. Your saved list stays with you across devices.

A sample issue

What a digest actually looks like.

Short, structured, cited. Designed to be skimmed between patients.

Evidence Digest

Illustrative

Sample issue · Musculoskeletal physiotherapy

Exercise loading for chronic lateral elbow tendinopathy: what the latest trial adds

3-minute read · 1 randomised controlled trial

Key findings

1
A 12-week progressive isotonic loading programme produced larger improvements in pain-free grip strength than a wait-and-see control at 12 weeks, with the between-group difference narrowing by 26 weeks.
2
Patient-reported function (PRTEE) improved in both arms; the loading group reached a clinically meaningful change a median 4 weeks earlier.
3
Adherence was the strongest predictor of 26-week outcome — completing ≥80% of prescribed sessions was associated with better functional gains, irrespective of arm.

Limitations: Single-centre trial, n=84, unblinded assessors for self-reported outcomes. Effect sizes attenuated at long-term follow-up; generalisability to overhead-athlete populations is limited.

Why this digest

Built for clinicians, not headlines.

Free, cited, AHPRA-safe, tuned to your field, delivered in-app and by email.

Free for clinicians

No card, no trial countdown. A standalone account, separate from Quicka's clinical software.

Cited and grounded

Every claim links back to the underlying study. We won't fabricate references — if we can't cite it, we don't say it.

AHPRA-safe framing

Educational summaries written for registered practitioners. No therapeutic guarantees, no patient testimonials, no prescription-product promotion.

Tuned to your field

Tailored to the conditions and populations you actually see. Less generic medical news, more useful evidence.

In-app and email

Read in the Quicka app or in your inbox. Same digest, your choice of surface.

Saveable reading list

Bookmark studies for a deeper read later. Build a personal library of evidence you trust.

Run a clinic?

Quicka also writes your notes, fills forms, and surfaces missed revenue.

Start a 14-day free trial of the full clinical workspace — no card required. Pushes notes to Cliniko and Nookal out of the box.

Start free trial

Frequently asked

Short answers to the things clinicians ask first.

Is it really free?: Yes. The evidence digest is a free product for registered clinicians. There is no card required and no trial that ends. The paid Quicka clinical software is separate.
How are studies chosen?: We surface recent, peer-reviewed work indexed in the major medical literature databases, filtered by the profession and interest areas you select. Summaries stick to what each paper reports — methods, findings, limitations — and link back to the source.
Do I need a Quicka account?: Yes, a lightweight free account. It takes about a minute and no payment details are collected. The account lets us tune the digest to your field and keep your saved reading list across devices.
Will summaries replace reading the paper?: No. The digest is a triage tool — it helps you decide which papers are worth your time. Every summary links to the original study so you can read the full text before changing practice.
Is it safe to share with my patients?: The digest is written for registered practitioners as continuing-education material, not for patient distribution. Apply your own clinical judgment before translating any finding into patient-facing advice.

Your next issue is one click away.

Free for clinicians. Cited. Tuned to your field. In-app and inbox.

Get my free digest